261 related articles for article (PubMed ID: 8569731)
1. Regulation of cellular Gs alpha levels and basal adenylyl cyclase activity by expression of the beta 2-adrenoceptor in neuroblastoma cell lines.
Milligan G; Kim GD; Mullaney I; Adie EJ
Mol Cell Biochem; 1995; 149-150():213-6. PubMed ID: 8569731
[TBL] [Abstract][Full Text] [Related]
2. Detection and analysis of agonist-induced formation of the complex of the stimulatory guanine nucleotide-binding protein with adenylate cyclase in intact wild-type and beta 2-adrenoceptor-expressing NG108-15 cells.
Kim GD; Carr IC; Milligan G
Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):275-81. PubMed ID: 7538756
[TBL] [Abstract][Full Text] [Related]
3. Expression of the human beta 2-adrenoceptor in NCB20 cells results in agonist activation of adenylyl cyclase and agonist-mediated selective down-regulation of Gs alpha.
Mullaney I; Shah BH; Wise A; Milligan G
J Neurochem; 1995 Aug; 65(2):545-53. PubMed ID: 7616208
[TBL] [Abstract][Full Text] [Related]
4. Agonist regulation of cellular Gs alpha-subunit levels in neuroblastoma x glioma hybrid NG108-15 cells transfected to express different levels of the human beta 2 adrenoceptor.
Adie EJ; Milligan G
Biochem J; 1994 Jun; 300 ( Pt 3)(Pt 3):709-15. PubMed ID: 7516655
[TBL] [Abstract][Full Text] [Related]
5. Regulation of basal adenylate cyclase activity in neuroblastoma x glioma hybrid, NG108-15, cells transfected to express the human beta 2 adrenoceptor: evidence for empty receptor stimulation of the adenylate cyclase cascade.
Adie EJ; Milligan G
Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):803-8. PubMed ID: 7980449
[TBL] [Abstract][Full Text] [Related]
6. Agonist regulation of adenylate cyclase activity in neuroblastoma x glioma hybrid NG108-15 cells transfected to co-express adenylate cyclase type II and the beta 2-adrenoceptor. Evidence that adenylate cyclase is the limiting component for receptor-mediated stimulation of adenylate cyclase activity.
MacEwan DJ; Kim GD; Milligan G
Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):1033-9. PubMed ID: 8836153
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the role of receptor number in defining the intrinsic activity and potency of partial agonists in neuroblastoma x glioma hybrid NG108-15 cells transfected to express differing levels of the human beta 2-adrenoceptor.
MacEwan DJ; Kim GD; Milligan G
Mol Pharmacol; 1995 Aug; 48(2):316-25. PubMed ID: 7651365
[TBL] [Abstract][Full Text] [Related]
8. Quantitative stoichiometry of the proteins of the stimulatory arm of the adenylyl cyclase cascade in neuroblastoma x glioma hybrid, NG108-15 cells.
Kim GD; Adie EJ; Milligan G
Eur J Biochem; 1994 Jan; 219(1-2):135-43. PubMed ID: 8306980
[TBL] [Abstract][Full Text] [Related]
9. Receptor availability defines the extent of agonist-mediated G-protein down-regulation in neuroblastoma x glioma hybrid cells transfected to express the beta 2-adrenoceptor.
Kim GD; Milligan G
FEBS Lett; 1994 Nov; 355(2):166-70. PubMed ID: 7982493
[TBL] [Abstract][Full Text] [Related]
10. Gs alpha-dependent and -independent desensitisation of prostanoid IP receptor-activated adenylyl cyclase in NG108-15 cells.
Williams RJ; Kelly E
Eur J Pharmacol; 1994 Jul; 268(2):177-86. PubMed ID: 7525317
[TBL] [Abstract][Full Text] [Related]
11. Concurrent down-regulation of IP prostanoid receptors and the alpha-subunit of the stimulatory guanine-nucleotide-binding protein (Gs) during prolonged exposure of neuroblastoma x glioma cells to prostanoid agonists. Quantification and functional implications.
Adie EJ; Mullaney I; McKenzie FR; Milligan G
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):529-36. PubMed ID: 1379045
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of inverse agonists in cells overexpressing a constitutively active beta2-adrenoceptor and type II adenylyl cyclase.
Stevens PA; Milligan G
Br J Pharmacol; 1998 Jan; 123(2):335-43. PubMed ID: 9489623
[TBL] [Abstract][Full Text] [Related]
13. Beta 3-adrenoceptor agonist-induced down-regulation of Gs alpha and functional desensitization in a Chinese hamster ovary cell line expressing a beta 3-adrenoceptor refractory to down-regulation.
Chambers J; Park J; Cronk D; Chapman C; Kennedy FR; Wilson S; Milligan G
Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):973-8. PubMed ID: 7980470
[TBL] [Abstract][Full Text] [Related]
14. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
Zeiders JL; Seidler FJ; Slotkin TA
J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E1-mediated, cyclic AMP-independent, down-regulation of Gs alpha in neuroblastoma x glioma hybrid cells.
McKenzie FR; Milligan G
J Biol Chem; 1990 Oct; 265(28):17084-93. PubMed ID: 2170366
[TBL] [Abstract][Full Text] [Related]
16. Exfoliation of the beta-adrenergic receptor and the regulatory components of adenylate cyclase by cultured rat glioma C6 cells.
Kassis S; Lauter CJ; Stojanov M; Salem N
Biochim Biophys Acta; 1986 May; 886(3):474-82. PubMed ID: 2871868
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas exotoxin A prevents beta-adrenoceptor-induced upregulation of Gi protein alpha-subunits and adenylyl cyclase desensitization in rat heart muscle cells.
Reithmann C; Gierschik P; Müller U; Werdan K; Jakobs KH
Mol Pharmacol; 1990 May; 37(5):631-8. PubMed ID: 1971089
[TBL] [Abstract][Full Text] [Related]
18. Expression and characterization of the long and short splice variants of GS alpha in S49 cyc- cells.
O'Donnell JK; Sweet RW; Stadel JM
Mol Pharmacol; 1991 Jun; 39(6):702-10. PubMed ID: 1646945
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the beta 2-adrenoceptor with epitope-tagged Gs alpha in NG108-15 cells.
Mullaney I; Milligan G
Biochem Soc Trans; 1995 Feb; 23(1):7S. PubMed ID: 7538951
[No Abstract] [Full Text] [Related]
20. Distinct pathways for beta-adrenoceptor-induced up-regulation of muscarinic acetylcholine receptors and inhibitory G-protein alpha-subunits in chicken cardiomyocytes.
Reithmann C; Panzner B; Werdan K
Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):530-40. PubMed ID: 1356232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
